All articles tagged with #cardiometabolic
Insulin resistance, which can be triggered by a high-sugar diet, aging, genetics, inactivity, and visceral fat, is increasingly seen as a central but overlooked contributor to cardiometabolic diseases such as heart disease, diabetes, and fatty liver, and may be linked to cancer risk as well.
A Harvard and Ben Gurion University study found that nearly one-third of individuals on healthy diets did not lose weight but still experienced significant improvements in metabolic health, challenging the notion that weight loss is the sole indicator of health success.
Novo Nordisk has entered into a partnership with Valo Health, a machine learning and drug discovery startup, to expand its cardiometabolic pipeline. In exchange for $60 million upfront and near-term payments, Novo will gain access to three cardiovascular assets developed by Valo. The deal also includes the potential for milestone payments of up to $2.7 billion for additional programs, as well as funding for R&D and potential royalties.